Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  anemia
Country:  U.S.A.
Trial Type:  Treatment
Results 1-7 of 7 for your search:
Start Over
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Status: Active
Phase: Phase IV
Type: Treatment
Age: 2 and over
Trial IDs: LA38-0411, NCI-2014-01229, NCT02041299
Rituximab and Pentostatin or Bendamustine Hydrochloride in Treating Patients with Relapsed or Refractory Hairy Cell Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-C-0025, NCI-2013-01455, P09576, NCT01059786
Sotatercept in Treating Patients with Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2012-0534, NCI-2012-03139, NCT01712308
Tumor Infiltrating Lymphocytes, Aldesleukin, Chemotherapy, and Pembrolizumab in Treating Patients with Metastatic Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 66
Trial IDs: 14-C-0022, NCI-2014-02337, P131421, NCT01993719
A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: C-935788-053, NCI-2016-00060, NCT02612558
Deferasirox in Treating Patients with Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 9422, NCI-2016-01457, NCT02943668
2-O, 3-O Desulfated Heparin and Azacitidine in Treating Patients with Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201608032, NCI-2016-02006, NCT02995655
Start Over